The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

類似資料

• The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
  著者:: Passweg, Jakob R., 等
  出版事項: (2019)
• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
  著者:: Passweg, Jakob R., 等
  出版事項: (2021)
• The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
  著者:: Ljungman, Per, 等
  出版事項: (2020)
• Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
  著者:: Ljungman, Per, 等
  出版事項: (2020)
• How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT
  著者:: Penack, Olaf, 等
  出版事項: (2020)